COMMUNIQUÉS West-GlobeNewswire

HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7
24/07/2018
TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report [...]
Emerald Health Therapeutics Signs Cannabis Supply Memorandum of Understanding with British Columbia Liquor Distribution Branch
24/07/2018
VICTORIA, British Columbia, July 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) has signed a Memorandum of Understanding ("MOU") with the British Columbia Liquor [...]
Loop Industries helps make Gatorade Gx packaging more sustainable
24/07/2018
Loop Industries help Gatorade Gx consumers recover and upcycle plastic TERREBONNE, Quebec, July 24, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP) today announced a free new program that allows consumers [...]
Geron to Announce Second Quarter 2018 Financial Results on July 31, 2018
24/07/2018
MENLO PARK, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that it will release its second quarter 2018 financial results after the market closes on Tuesday, July 31, 2018. The [...]
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
24/07/2018
ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
24/07/2018
LONDON and OXFORD, United Kingdom, July 24, 2018 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc and Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced the transition of the [...]
Freedom Laser Therapy Expands iRestore Reseller Program For Hair Care Professionals
24/07/2018
Company Introduces New Affiliate Card Program for the iRestore Laser Hair Growth System LOS ANGELES, July 24, 2018 (GLOBE NEWSWIRE) -- Freedom Laser Therapy , creator of the FDA cleared and clinically proven iRestore [...]
Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018
24/07/2018
SAN DIEGO and TORONTO, July 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Immuron Announces it has Received a European Patent Grant for NASH treatment
24/07/2018
MELBOURNE, Australia, July 24, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is an Australian microbiome biopharmaceutical Company focused on developing and commercializing orally delivered targeted [...]
US Department of Defense Research Collaboration Moves Forward
24/07/2018
Key Highlights: Three US Defense Health funded research projects on Travelan® successfully completed Studies commissioned by the US Department of Defense to evaluate Travelan®’s ability to neutralise pathogenic bacteria [...]
Industry Accolades for Saccade Analytics Groundbreaking Neurological Evaluation Tool
24/07/2018
Awards Recognizing Innovation and Rapid Growth Keep Accruing for the Canadian Medical Software Start-Up Saccade Analytics MONTREAL, July 24, 2018 (GLOBE NEWSWIRE) -- Saccade Analytics is pleased to announce that it has [...]
EDAP TMS SA : EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30
24/07/2018
LYON, France, July 24, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter and six months ended June 30, 2018 [...]
Dr. Thomas A. Finley, M.D. Appointed as Chairmen of Ocutrx International Medical Advisory Board
24/07/2018
Oculenz™ AR Glasses Garners Important Medical Support for Restoring Functional Sight to Patients with Visual Field Deficits IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California [...]
Amarin to Report Second Quarter 2018 Results and Host Conference Call on August 1, 2018
24/07/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, July 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Transactions in relation to share buyback program
24/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ViroGates Releases Second Quarter 2018 Financial Results
24/07/2018
Company announcement no. 4-2018 Birkerød, 24 July 2018 ViroGates Releases Second Quarter 2018 Financial Results ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for the Emergency [...]
Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance
24/07/2018
Safety and pharmacodynamic effects of seliforant compared to meclizine MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner [...]
Idorsia announces financial results for the first half 2018
24/07/2018
Allschwil, Switzerland - July 24, 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented: "We have made significant [...]
AC Immune Announces Closing of First Subscription Rights Offering and Primary Offering as well as Full Exercise of Option to Purchase Additional Shares
24/07/2018
Lausanne, Switzerland, July 24, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the closing of its previously announced [...]

Pages